Biotechnology progress
CRISPR-Cas9 lipid nanoparticles for targeting cyclin-dependent kinases in the tumor microenvironment.
Mohammad Mashreghi, Mahere Rezazade Bazaz, Mahmoud Reza Jaafari
Published: 202610.1002/btpr.70105
Abstract
Due to the significant roles of cyclin-dependent kinases 4 and 6 (CDK4/6) in cancer progression, this study aimed to introduce clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) plasmid DNA (pDNA) en…
Preview only. Read the full abstract at the source